China SXT Pharmaceuticals, Inc. (SXTC) stock
SXTCNasdaqPharmaceutical PreparationsFiscal year ends March 31
$3.00+0.27 (+9.89%)
Close on Nov 13, 2026Market cap $2.87MP/E –Yield –
China SXT Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2026 it was -625.9%, against -154.0% the year before. The highest annual figure on record is 32.8% in fiscal 2017.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -625.9% | −471.9 |
| FY2025 | Mar 31, 2025 | -154.0% | −23.5 |
| FY2024 | Mar 31, 2024 | -130.4% | +154.0 |
| FY2023 | Mar 31, 2023 | -284.4% | −85.0 |
| FY2022 | Mar 31, 2022 | -199.4% | −153.4 |
| FY2021 | Mar 31, 2021 | -46.0% | −20.0 |
| FY2020 | Mar 31, 2020 | -26.0% | −51.2 |
| FY2019 | Mar 31, 2019 | 25.2% | +2.0 |
| FY2018 | Mar 31, 2018 | 23.3% | −9.6 |
| FY2017 | Mar 31, 2017 | 32.8% | – |
See a number that looks wrong?